Sanara MedTech Inc SMTI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SMTI is a good fit for your portfolio.
News
-
Sanara MedTech Inc. Announces $55 Million Debt Facility
-
Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer
-
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results
-
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Dates
-
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023
-
Sanara MedTech Gets 510(k) Clearance for Biasurge
Trading Information
- Previous Close Price
- $32.50
- Day Range
- $31.53–32.82
- 52-Week Range
- $26.06–46.40
- Bid/Ask
- $31.81 / $32.99
- Market Cap
- $277.74 Mil
- Volume/Avg
- 14,276 / 13,313
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.10
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 108
- Website
- https://www.sanaramedtech.com
Comparables
Valuation
|
Metric
|
SMTI
|
ZIMV
|
02373
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 9.49 | 15.46 |
Price/Book Value | 6.13 | 1.02 | 4.20 |
Price/Sales | 4.10 | 0.90 | 1.52 |
Price/Cash Flow | 7,912.06 | 12.03 | 5.53 |
Price/Earnings
SMTI
ZIMV
02373
Financial Strength
|
Metric
|
SMTI
|
ZIMV
|
02373
|
|---|---|---|---|
Quick Ratio | 0.99 | 0.84 | 0.85 |
Current Ratio | 1.38 | 2.78 | 0.94 |
Interest Coverage | −8.33 | −1.51 | 11.74 |
Quick Ratio
SMTI
ZIMV
02373
Profitability
|
Metric
|
SMTI
|
ZIMV
|
02373
|
|---|---|---|---|
Return on Assets (Normalized) | −6.84% | 14.12% | 7.50% |
Return on Equity (Normalized) | −10.51% | 31.63% | 39.20% |
Return on Invested Capital (Normalized) | −8.32% | 18.79% | 19.88% |
Return on Assets
SMTI
ZIMV
02373
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Dsrhrjrcs | Mmpb | $133.8 Bil | |
BDX
| Becton Dickinson & Co | Cxdzwfgc | Jnhclvr | $67.6 Bil | |
ALC
| Alcon Inc | Xlvbqkgq | Mwbzmx | $39.1 Bil | |
WST
| West Pharmaceutical Services Inc | Fytjdcvnj | Jfnc | $28.6 Bil | |
CLPBY
| Coloplast A/S ADR | Npgdgybflz | Szkr | $27.9 Bil | |
RMD
| ResMed Inc | Jxhpjtgcr | Pwzkkdq | $27.0 Bil | |
BAX
| Baxter International Inc | Bpyxxlmbk | Kfcdc | $20.9 Bil | |
COO
| The Cooper Companies Inc | Kcdtwldg | Lnrvzjy | $17.9 Bil | |
HOLX
| Hologic Inc | Bhfngflc | Frksbtd | $17.8 Bil | |
TFX
| Teleflex Inc | Rdtkh | Gsv | $9.9 Bil |